rs150549982
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4BA1
This summary comes from the ClinGen Evidence Repository: NM_001034853.2(RPGR):c.1240G>C is a missense variant predicted to cause the substitution of glutamate by glutamine at amino acid 414. This variant is present in gnomAD v.4.1.0 at a frequency of 0.00008303 among hemizygous individuals, with 33 variant alleles / 397,426 total alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.00005 (BA1). The computational predictor REVEL gives a score of 0.119, which is below the ClinGen X-linked IRD VCEP threshold of < 0.183 and predicts a non-damaging effect on the RPGR function. Additionally, the splicing impact predictor SpliceAI gives a delta score of 0.02, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on splicing (BP4_moderate). In summary, this variant is classified as benign for RPGR-related retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen X-linked IRD VCEP: BA1, and BP4_moderate. (VCEP specifications version 1.0.0; date of approval 05/16/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA10385514/MONDO:0100437/106
Frequency
Consequence
NM_001034853.2 missense
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 3Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- RPGR-related retinopathyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- primary ciliary dyskinesia-retinitis pigmentosa syndromeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- macular degeneration, X-linked atrophicInheritance: XL Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RPGR | ENST00000645032.1 | c.1240G>C | p.Glu414Gln | missense_variant | Exon 10 of 15 | NM_001034853.2 | ENSP00000495537.1 | |||
| ENSG00000250349 | ENST00000465127.1 | c.172-367160C>G | intron_variant | Intron 3 of 8 | 5 | ENSP00000417050.1 |
Frequencies
GnomAD3 genomes AF: 0.000473 AC: 53AN: 111966Hom.: 1 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.000158 AC: 29AN: 183397 AF XY: 0.000118 show subpopulations
GnomAD4 exome AF: 0.0000592 AC: 65AN: 1097871Hom.: 0 Cov.: 30 AF XY: 0.0000606 AC XY: 22AN XY: 363247 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000473 AC: 53AN: 112019Hom.: 1 Cov.: 23 AF XY: 0.000322 AC XY: 11AN XY: 34179 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
X-linked cone-rod dystrophy 1;C1845667:Retinitis pigmentosa 3;C2749137:Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness;C3151784:Macular degeneration, X-linked atrophic Benign:1
- -
Primary ciliary dyskinesia Benign:1
- -
RPGR-related retinopathy Benign:1
NM_001034853.2(RPGR):c.1240G>C is a missense variant predicted to cause the substitution of glutamate by glutamine at amino acid 414. This variant is present in gnomAD v.4.1.0 at a frequency of 0.00008303 among hemizygous individuals, with 33 variant alleles / 397,426 total alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.00005 (BA1). The computational predictor REVEL gives a score of 0.119, which is below the ClinGen X-linked IRD VCEP threshold of < 0.183 and predicts a non-damaging effect on the RPGR function. Additionally, the splicing impact predictor SpliceAI gives a delta score of 0.02, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on splicing (BP4_moderate). In summary, this variant is classified as benign for RPGR-related retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen X-linked IRD VCEP: BA1, and BP4_moderate. (VCEP specifications version 1.0.0; date of approval 05/16/2025). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at